MENU
+Compare
AMPH
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$39.07
Change
-$0.32 (-0.81%)
Capitalization
2.11B

AMPH Amphastar Pharmaceuticals Forecast, Technical & Fundamental Analysis

a manufacturer of proprietary injectable and inhalation products

AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for AMPH with price predictions
Dec 20, 2024

Momentum Indicator for AMPH turns negative, indicating new downward trend

AMPH saw its Momentum Indicator move below the 0 level on December 05, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for AMPH turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for AMPH crossed bearishly below the 50-day moving average on November 15, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMPH entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMPH advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.265) is normal, around the industry mean (58.252). P/E Ratio (16.692) is within average values for comparable stocks, (90.460). AMPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.570) is also within normal values, averaging (19.472).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AMPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AMPH is expected to report earnings to 96 cents per share on March 12

Amphastar Pharmaceuticals AMPH Stock Earnings Reports
Q4'24
Est.
$0.97
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.17
Q1'24
Beat
by $0.26
Q4'23
Missed
by $0.03
The last earnings report on November 06 showed earnings per share of 95 cents, missing the estimate of $1.00. With 2.48M shares outstanding, the current market capitalization sits at 2.11B.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary injectable and inhalation products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11570 6th Street
Phone
+1 909 980-9484
Employees
1761
Web
https://www.amphastar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMJX5.810.11
+1.93%
Invesco SteelPath MLP Alpha Plus R
GGOUX21.850.39
+1.82%
Goldman Sachs Mid Cap Growth R6
ETAGX50.220.76
+1.54%
Eventide Gilead A
WDIIX13.220.16
+1.23%
Wilmington Enhanced Div Inc Strat I
CDIRX33.060.30
+0.92%
Columbia Dividend Income R

AMPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with SUPN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-0.63%
SUPN - AMPH
35%
Loosely correlated
-0.95%
DVAX - AMPH
32%
Poorly correlated
-0.31%
EOLS - AMPH
28%
Poorly correlated
+0.18%
HROW - AMPH
28%
Poorly correlated
-0.61%
VTRS - AMPH
28%
Poorly correlated
+3.22%
More